A
group of highly experienced refractive surgeons
share its hard-won expertise in helping you
lower the LASIK learning curve, avoid mistakes
and maximize patient outcomes. |
There is no doubt that laser in situ
keratomileusis (LASIK) has enjoyed enormous popularity
and, for the most part, well-deserved success as the
procedure of choice among patients and surgeons for
the majority of refractive errors. Of the 940,000 laser
refractive procedures performed in the United States
last year, 846,000 were LASIK; a significant increase
from the 360,000 LASIK procedures done in 1998. Optimistic
projections for the year 2000 put total laser refractive
procedures at 1.65 million, of which 1.485 million
are expected to be LASIK. (Source: Spectrum Consulting)
As with any medical procedure,
an increase in the number of surgeries is usually accompanied
by a concomitant rise in that procedure's complication
rate. LASIK is no exception. This roundtable brings
together a group of highly experienced refractive surgeons
to share their hard-won expertise in helping you lower
the LASIK learning curve, avoid mistakes and maximize
patient outcomes.
- Leslie B. Sabbagh
Leslie B. Sabbagh
- Roundtable moderator
- Editor-in-Chief, Review of Refractive Surgery
- Consulting Editor, Review of Ophthalmology
|
Alan N. Carlson,
M.D.
- Associate Professor of Ophthalmology, Duke
University Eye Center, Durham, N.C.
- Chief of the Cornea! and External Disease
Service and the Refractive Surgery Service,
Duke University Eye Center. Durham. N.C.
|
Eric Donnenfeld,
M.D.
- Medical Director, TLC Garden City, N.Y.
- Assistant Clinical Professor of Ophthalmology,
Cornell University Medical College
- Co-Chair, External Disease and Cornea, Manhasset
Eye And Ear and North Shore Hospitals, Long
Island, N.Y.
|
A. John Kanellopoulos,
M.D.
- Clinical Professor of Ophthalmology,
New York University Medical School
- Assistant Director of Residency Training,
Manhattan Eye, Ear and Throat Hospital
- Practices in Manhattan and Athens
|
Steven E. Wilson,
M.D.
- Professor and Chair of the Department of
Ophthalmology, University of Washington
- PRK and LASIK instructor for VisX, Bausch & Lomb
and Summit Technologies
- Chief Medical Editor, Review of Refractive
Surgery
|
Mihai Pop,
M.D.
- Montreal, Canada
- Internationally recognized authority in
refractive and cataract surgery
- Medical director of Michel Pop Clinics in
Montreal and Hull. Canada
|
THE
PREOPERATIVE EXAM
MS.
SABBAGH: What in the preoperative exam helps
you to prevent potential complications?
DR. WILSON:
I look for ectatic dystrophies and contact lens warpage
on topography. Recently, I have paid much more attention
to evidence of dry eye disease because it helps me
predict patients at risk for LASIK-induced neurotrophic
epitheliopathy (LINE). Although the condition occurs
independently of dry eye disease, those with dry eyes
have a much greater incidence of LINE. I use nonreserved
artificial tears, ointments, and punctal plugs for
dry eyes, and treat meibomian gland disease.
DR. DONNENFELD:
I screen for corneal ectasia and irregular astigmatism,
and perform pachymetry. I pretreat mei- bomianitis
with doxycycline, 100 mg b.i.d. for two weeks, hot
compresses and good hygiene; and I prescribe non-preserved
lubricating drops. If patients have conjunctival staining,
then I maximize the ocular surface. Frank corneal staining
preoperatively is a strong contraindication not to
do surgery. I look at the preoperative topography,
refraction and autorefraction. If the axis is off 10
degrees between one of them, I always double-check
the refraction to make certain that I have the right
prescription.
DR. POP: Patient
expectations are key. Some patients have enjoyed 20/15
corrected vision from their teens. Post-LASIK, they
may be less than pleased with 20/20 uncorrected. Although
I agree that contact lens-intolerant patients can experience
difficulty, many of these patients do very well postop.
In my hands, often the least happy patients are low
myopes who have no preop pathology, yet acquire dry
eye syndrome. I believe patients with any amount of
asymmetrical astigmatism should not be treated because
the potential for keratic disease is much higher.
DR. CARLSON:
In my practice, every patient receives a detailed examination
to ensure that there are no medical or psychological
contraindications to surgery. The ability to achieve
outcomes that satisfy patients relates directly to
the ability to meet or exceed their expectations.
DR. KANELLOPOULOS:
I routinely plug the lower puncta of patients at risk
for dry eye disease immediately after the procedure
and give viscous, preservative-free tears, such as
Celluvisc, for the first day. I co-manage most of my
patients, and it's helpful to explain what they will
experience in the first month. For example, I discuss
postop dryness; a slight hyperopic shift in over-40
patients and the need for transient presbyopic glasses;
and the possibility of retreatment, especially in patients
over -6 D.
DR. WILSON:
Screening for anterior basement membrane dystrophy
must be done preoperatively. These patients have a
much higher likelihood for epithelial slough during
flap creation. The majority do well, but have a more
protracted recovery period and a tendency for regression
of effect. If these patients are also low myopes, I
consider PRK.
DR. CARLSON:
Contact lens intolerance should alert the surgeon to
the possibility of basement membrane dystrophy or loose
epithelium. I'm also wary of patients who are only
happy with rigid gas permeable contact lens vision,
especially if they have high degrees of regular astigmatism
or significant amounts of irregular astigmatism. They
may not be satisfied with LASIK. There is obvious concern
over creating a free cap in a patient with extremely
flat corneas, but I'm also concerned about the quality
of vision in a patient who may end up with a final
keratometry reading below 35 D. Unusually steep cases,
particular- ly hyperopic patients, also require caution.
Patients with axial hyperopia occasionally have steep
corneas preoperatively, and LASIK may produce an unacceptably
steep topography resembling keratoconus. GLAUCOMA
PATIENTS
MS. SABBAGH: What is your protocol
for treating glaucoma patients?
DR. DONNENFELD: I treat patients
with normal or mini- mally compromised visual fields
if they are in the care of a good glaucoma specialist.
I discontinue all glaucoma medications preop to avoid
epithelial toxicity and prescribe an oral medication,
such as Neptazine 50 mg b.i.d., to achieve glaucoma
control.
DR. POP: Treating patients with
another ocular pathology, such as glaucoma, can be
difficult from a psychological standpoint. For example,
if their glaucoma worsens postop, they may blame LASIK,
even though their condition is unrelated to the surgery.
If their visual field is com- promised, I don't perform
LASIK.
DR. KANELLOPOULOS: The glaucoma
patient brings three challenges: potential epithelial
toxicity; possible neuronal damage caused by the high
vacuum stage of the microkeratome; and the measurement
of IOP postoperatively. In a patient with a visual
field deficit, I avoid LASIK. The jury is still out
on whether an efficient LASIK surgeon causes any neuronal
damage by significantly increasing pressure for about
15 seconds, but this needs to be better evaluated.
DR. WILSON: I agree with being
very careful about treating glaucoma patients. But
whether we damage the nerve fiber layer or the optic
nerve itself is controversial. I think that most preliminary
reports using nerve fiber layer analyzers are confounded
by LASIK-induced corneal changes, which alter the measurements.
DR. DONNENFELD: Glaucoma patients
have a 50 percent chance to be steroid-responders;
I am much more comfortable raising the IOP for 15 seconds
with the microkeratome vacuum than putting a patient
on a three- month steroid course due to PRK-induced
corneal haze. I perform LASIK routinely on patients
with mild glaucoma. Patients with advanced glaucoma
should not have refractive procedures.
DR. CARLSON: I share the concern
about performing LASIK on patients with advanced or
poorly controlled glaucoma. I've operated successfully
on several prospective trabeculectomy patients with
high degrees of refractive error and astigmatism. LASIK
is not an option in eyes that already have a filtering
mechanism.
DR. WILSON: I have not yet seen
late haze in patients treated for less than -5 D with
PRK in about 3,000 PRK procedures. But as patients
become progressively more myopic, my concern heightens;
my typical PRK patient receives FML q.i.d. for one
week - never longer. It may even be possible to stop
treatment after the first day, according to John Marshall's
study. 1
DR. POP: The new techniques with
PRK are much safer and more effective with the second-generation
lasers. Using my laser with a slit-scanning system,
I see no haze; topical steroids are unnecessary for
treatments of-5 D and lower.
POSTERIOR SEGMENT
PATHOLOGY
MS. SABBAGH: When do you refer
to a retinal specialist?
DR. CARLSON: I refer any patient
with a suspicious peripheral retinal pathology or previous
retinal treatment. We have a large retinal service
at Duke, and many of my patients have had scleral buckling
procedures. I like to have the blessing of the retina
subspecialist before performing laser refractive surgery
on these patients.
DR. DONNENFELD: A retinal subspecialist
should evaluate any patient with obvious preoperative
pathology. I get a preop retinal consultation for any
patient who has more than -8 D because of the high
risk for postop problems. In addition, after their
postoperative care is complete, I advise high myopes
to have annual dilated exams.
DR. KANELLOPOULOS: In my international
practice, I use bioptics, a combination of LASIK and
a phakic intraocular lens, on patients who have from
10 D to 25 D of myopia. A microkeratome flap is made,
then an Artisan lens is inserted; the patient is refracted
six weeks later when the refraction is stable and some
of the cylinder induced by intraoperative cautery has
resolved. Finally, LASIK is performed for the residual
refractive error.
DR. WILSON: I have seen two posterior
vitreous detachments very early after LASIK in patients
with more than -8 to-10 D.I advise patients that studies
have not shown that LASIK is associated with retinal
detachment, but I still have some concern.
CORNEAL TOPOGRAPHY
MS.
SABBAGH: What role does topography play?
DR. KANELLOPOULOS:
There's general agreement that topography is the essential
tool for refractive surgery, with wavefront technology
taking on a larger role to further evaluate LASIK patients.
For patients who show any sign of asymmetric astigmatism,
I obtain an Orbscan image. I'm particularly interested
in the posterior corneal curvature of patients with
irregular astigmatism.
DR. POP: I
use the EyeSys 2000, version 2.1 and the Tomey TMS-I.
In cases of astigmatism or corneal surface change,
I look for a skewed pattern deviation on the steep
meridian. I also regularly use the asphericity index
or Q value if asymmetry or astigmatism is seen on topography.
DR. DONNENFELD:
We use topography in every patient. Keratectasia must
be suspected in cases of pro- gressive myopia following
LASIK. Retreatments are con- traindicated in eyes with
progressive corneal steepening post-LASIK.
DR. KANELLOPOULOS:
Often I see topographic images that consist of two
small pictures on one piece of paper. I prefer full-page
topography because it reveals a great deal of anterior
pathology that is not apparent clinically.
DR. CARLSON:
I find it helpful to perform a repeat topography while
watching the stability of the corneal mires on the
screen. This helps assess the stability of the image
between blinking and also whether surface pathology
is interfering with the quality of the mires. I use
topography with other measurements, including manifest
and cycloplegic refractions for overall consistency
evaluating both the magnitude and the quality of corneal
astigmatism prior to treatment. Topography is extremely
helpful in identifying patients with contact lens over-wear
or improperly fitting contact lenses. I ask tone soft
lens patients to remove their lenses three weeks prior
to surgery. I ask RGP patients to stay out of their
lenses three to four weeks for every decade of wear.
Still, I've had several patients who did not have stable
refractions and topographies six months out of Phakic
contact lenses.
DR. WILSON:
Any of the available corneal topography instruments
do a great job imaging the anterior surface topography.
I have concerns about the accuracy and reliability
of posterior curvature changes measured with the Orbscan.
Robert Maloney has made important points about some
of these apparent ectasias in patients who had LASIK
for 3 or 4 D of myopia being attributable to errors
inherent in measurement with that instnunent.2
DR. KANELLOPOULOS:
The Orbscan may not be the most accurate instrument
in measuring corneal pachymetry, but it leads us in
the right direction. Dan Reinstein has done some interesting
work with high frequency, digital ultrasound pachymetric
mapping of LASIK's effects on the corneal epithelium
and stromil.3
DR. POP: Topography
is important, but retinoscopy gives even more insight.
DR. CARLSON:
Assessing the retinoscopic reflex is very helpful in
determining why patients, who may have improved from
20/200 to 20/20 on their first day, still complain
about the quality of their vision. You can see edema
on retinoscopy that you cannot see by slit lamp examination.
Also, this is the most helpful way of assessing the
visual significance of striae. PUPIL SIZE
MS.
SABBAGH: How important is pupil size and
how do you measure it in normal and low light?
DR. CARLSON:
Our technicians measure the pupils with a pupil gauge
under normal illumination, then under scotopic illumination.
The significance of the pupil size increases in patients
with high degrees of spherical correction and astigmatism;
these patients may also be intolerant of glare or
have reduced contrast sensitivity. There's a significant
psychological factor: Some patients are more tolerant
than others are, and I think that plays a role in
their ultimate satisfaction with the outcome.
DR. DONNENFELD:
We don't use a pupil-measuring device: I initially
evaluate patients in a dark room. The second evaluation
of pupil size occurs during the procedure. The non-operative
eye is covered and I turn the light down on the operating
microscope and look at the operative under the microscope
with the reticle, which gives the exact size of the
pupil.
We treat patients
with larger pupils, significant cylinder and/or high
myopia with larger ablation zones. We use the VisX
Star II for most procedures, however, for larger
pupils we've had great results, with minimal glare,
using the Chiron/B&L Technolas laser. We can achieve
ablation zones of 14 and 15 mm and optical zones
of 7 mm.
DR. POP:
We studied glare and halos in 1,300 patients' and
discovered only two risk factors for glare: myopia
over 5 D, and 6-mm optical zone ablation without
a transition zone. In these eyes I suggest using
a transition zone 1to 2 mm from the optical zone.
DR. KANELLOPOULOS:
I use the Oasis pupillometer routinely. Patients
with high astigmatism and myopia and large pupils
have more problems with glare and halos when a small
zone ablation is used. I think LASIK creates a large
amount of aberration in higher myopes.
DR. WILSON:
I use the Humphrey 992 topographer with a printout
including corneal maps and video keratoscope images
on the same page. Pupil size seems more important
in high myopia, but even there the correlation isn't
always strong. PREPARING THE SURGICAL
FIELD
MS.
SABBAGH: How do you prepare the surgical
field to avoid intraoperative problems?
DR. CARLSON:
I use a Betadine prep and drape the upper and lower
lids to isolate the lashes and meibomian glands.
I use one drop ofproparacaine on the ocular surface,
then use a Merocel sponge soaked with proparacaine
in the fomix prior to draping. I have used a locking
speculum, but now use a non-locking wire speculum;
patients find it more comfortable and we achieve
better exposure.
DR. DONNENFELD:
Early on, we gave anesthetics up to half-hour before
surgery and saw a significant number of epithelial
sloughs intraoperatively. We now instill the anesthetic
in the operating suite. I generally only drape the
upper lids and use a locking lid speculum. Patients
who have the most flap complications are usually
those in whom you can't get good exposure. We just
finished clinical trials on a new microkeratome,
Allergan's Amadeus, and were very impressed with
the exposure we achieved with the instrument.
DR. WILSON:
I instill anesthetic in the first eye when the patient
is in the laser room, then I mark both corneas. I
don't instill anesthetic in the second eye until
the first eye is finished and we're about to prep
the second eye. We've done a small study that showed
inconsistency between the first and second eyes when
both are anesthetized at the same time. Since we
stopped instilling anesthetic in both eyes simultaneously,
we no longer see that variability.
DR. DONNENFELD:
We place Celluvisc, about 30 seconds after the procedure,
to apply focal pressure to the cornea, remove striae
and protect the epithelium until the anesthetic wears
off. Since we've begun using this technique, we've
been very pleased with the clarity of the corneas
and the lack ofepitheliopathy.
DR. WILSON:
An aspirating lid speculum is very helpful in removing
any material from the surface of the eye during irrigation,
including meibomian gland secretions. Removal of
this material helps keep the interface cleaner. DR.
POP: My staff and I wear sterile gloves, but I don't
drape the patient nor do I scrub the eyelids; in
more than 20,000 refractive surgery cases, we've
seen no infection. I wipe all the instruments inserted
beneath the flap on a wet sponge that also isolates
the lashes. I often don't use a speculum for cases
with tight lids; instead I find that the Moria LSK
ONE microkeratome plate does a good job separating
the lids.
During surgery,
I use the Chayet sponge to protect the flap. After
the cut is made, I fold the flap on itself so that
the epithelial surface is exposed rather than the
stroma, and the inside of the flap is completely
protected from any meibomian gland secretions. Because
it is folded like a sandwich, the edge of the flap
protects the hinge during ablation. We've seen no
difference in the flap postop.
DR. DONNENFELD:
If I see significant meibomian gland secretion, I
tilt the patient's head to the side and copiously
irrigate the cul-de-sac. Trying to irrigate without
tilting pools the meibomian gland secretions, but
turning the patient's head to the side lets them
flow out of the eye. Intraoperatively, I irrigate
copiously to create a positive hydrostatic pressure
before replacing the flap.
DR. KANELLOPOULOS:
I use nonpowdered gloves and an aspirating speculum.
I avoid any manipulation of the flap. I drape patients'
upper lids when using the ACS or Krumeich-Barraquer
microkeratome to avoid interference with the upper
lashes; and I drape the lower lids when using the
Hansatome or Moria because those devices touch the
lower lashes.
DR. CARLSON:
Prior to reflecting the corneal flap, I wring out
a Merocel sponge that was moistened with BSS and
dry the gutter. This produces a dry bed when the
flap is lifted, allowing treatment without further
drying or manipulating. My co-managing doctors have
noticed a significantly improved interface with this
technique.
TREATING
FLAP COMPLICATIONS
MS. SABBAGH: How do you manage
flap complications?
DR. WILSON: For partial cuts,
I replace the flap, wait three months and recut the
cornea. For buttonhole flaps with central scarring
or epithelial ingrowth, I use transepithelial PRK to
remove the central flap completely. I've performed
this in two of my own patients and about 15 referred
patients. The transepithelial PRK is done two weeks
after the first attempt when BCVA is as close to preop
as possible.
Relation Between Optical Zone,
Transition Zone, Refraction and Halos
 |
| Measure |
Statistical
Relation to Halos |
| Pupil size |
No |
| Limbus |
No |
| Optical zone |
No |
| Keratometry |
No |
| Pachymetry |
No |
| Transition zone |
Yes |
| Preoperative refraction |
Yes |
 |
| - MIHAI POP, M.D. |
|
DR. DONNENFELD: I treat a free
cap with a bandage contact lens for patient comfort;
an antibiotic until the eye re-epithelializes and Pred
Forte q.i.d. tapered over three months. Well-healed
eyes usually achieve 20/30; a poor result might require
lamellar keratoplasty.
DR. CARLSON: Once the flap is
created, I lift it to make sure that it's not exposed
to asymmetric hydration. The ablation is performed
efficiently; the flap is repositioned; and the bed
is briskly irrigated with 2 cc of BSS.
DR. DONNENFELD: I try to maintain
an intact epithelium to maximize adherence to the flap.
I examine every patient 15 minutes after LASIK, and
use a Q-Tip to gently smooth out any microstriae. This
works extremely well for high myopes.
DR. POP: I immediately remove
the speculum to stop corneal dehydration after the
flap is replaced; striae are created through excessive
flap desiccation that can occur within a minute or
two of the procedure. The most important thing is to
examine the gutter after 10 to 15 minutes. If the gutter
is not completely symmetric, I irrigate the flap slightly
and replace it.
We no longer shield the eye. Many patients
displace their flap by wiping their eyes and they'll
try to reach under any shield. Patients are instructed
to go home and sleep for three to four hours. Since
using this protocol, our striae rate is less than I
percent.
DR. KANELLOPOULOS: I try to create
a thick flap, and agree that sufficient lubrication
is key immediately postop to prevent the flap from
dislodging due to blinking. I prefer that the eye remain
open with the aspirating speculum for two minutes to
avoid the mechanical stresses of the lids on the flap.
I examine the patient 15 minutes postop for any striae.
DR. WILSON: I allow the flap to
adhere for 30 seconds. We insert a Soflens 66 bandage
contact lens for the first night. This adds to patient
comfort and protects the edge of the flap from eyelid
movement. Even a slight displace-ment, just a partial
lifting of the flap, can be enough to produce significant
striae or allow epithelial ingrowth.
TREATING
STRIAE
MS. SABBAGH: How do you assess
whether striae require treatment?
DR. CARLSON: I exam the patients
at the slit lamp with indirect retroillumination. In
the early postoperative period, in cases of central
striae, I perform a retinoscopy. This is extremely
helpful to assess the significance, particularly if
I can see that the defect on the retinoscopic streak
matches with what I see at the slit lamp. Other tests
include fluorescein staining for pooling in the trough
of the striae, and comparing the quality of vision
with a rigid contact lens to their best-corrected spectacle
acuity. This can help determine if a corneal irregularity
exists causing reduced quality of vision.
DR. DONNENFELD: I massage striae
on the first day of surgery with a Q-Tip and a topical
anesthesia. For striae between one and four days, I
refloat and slightly stretch the flap. From five to
10 days, I refloat the flap and apply heat to relax
the collagen fibrils so we can reposition the cornea
with hypotonic saline. For folds or striae of two weeks
and longer, I debride the epithelium, then using hypotonic
saline, lift and heat the flap. I replace and massage
it with a Merocel sponge and apply a bandage contact
lens. A very hypotonic tear soaks the bandage contact
lens, keeping the cornea edemic and preventing reformation
of the striae.
DR. WILSON: If a patient complains
about vision in the first few days after surgery and
has striae, I refloat the flap using 50% BSS to maintain
a hypotonic environment. When the flap is first replaced,
some striae are apparent at the slit lamp; over the
next 24 hours these resolve.
DR. KANELLOPOULOS: I take no action
when striae are present in a happy 20/20 patient. If
they reduce BCVA, cause glare or irregular topography,
I use a combination of hypotonic solution and hyperthermia.
I use a golf-club spatula dipped in a sterile hypotonic
solution preheated to 65° C; applying this irons out
the striae from the retracted flap by softening the
collagen fibrils. A preheated Johnston applanator is
placed over the repositioned flap at the end of the
procedure to press out the folds.
DIFFUSE
LAMELLAR KERATITIS
MS. SABBAGH: What's your threshold
for treating DLK?
DR. CARLSON: I aggressively treat
patients who present on day one with even mild DLK
with topical corticosteroids. I have placed a few patients
on oral corticosteroids, and sometimes oral doxycycime.
If patients on hourly topical corticosteroids worsen
the next day, then I irrigate under the flap. All my
patients with DLK also had some degree of rosacea and
significant meibomian gland disease. It's possible
that these patients have a propensity for white cell
migration into the cornea. Infection must be considered
in the differential diagnosis in any patient with corneal
inflammation postoperatively.
DR. POP: It is difficult to overtreat
DLK. Often, the condition presents only in the upper
or inferior quadrant of the cornea and extends only
I or 2 mm. It's best to prescribe Pred Forte every
hour and watch patients carefully, because the condition
can worsen over two to three days.
DR. DONNENFELD: I use 60 mg ofprednisone
for three days orally for significant DLK. My threshold
for lifting the flap and irrigating is low. I am careful
not to scrape the stroma and irrigate aggressively
with BSS.
DR. KANELLOPOULOS: I'm very aggressive
in irrigating the interface. Although I can't statistically
support it, I see more DLK when I am unable to use
an aspirating speculum. I recently had a case diagnosed
as DLK that was actually ciprofloxacin deposits. Now
I strictly adhere to more soluble antibiotics.
DR. WILSON: Appropriate irrigation
after ablation is critical in reducing DLK. In substantial
DLK cases, lift the flap and irrigate to avoid necrosis
along the interface.
TREATING INFECTION
MS. SABBAGH: What is your preferred
regimen for treating infection?
DR. WILSON: After taking fungal
and bacterial cultures, I immediately prescribe fortified
antibiotics; my regimen of choice is vancomycin 15
mg/mL and amikacin 20 mg/mL every hour around the clock.
DR. KANELLOPOULOS: I have not
seen bacterial keratitis, but my choice would be fortified
tobramycin 12 to 14 mg/mL with a cephalosporin (Cefuroxime
50 mg/mL). I have consulted internationally in a referred
fungal keratitis case. That is challenging clinically,
because the cultures usually take several weeks, and
meanwhile it's difficult to treat a LASIK patient with
antifungals, even if it is the differential diagnosis.
This is one of the reasons why I adhere to a strict
sterility protocol.
DR. CARLSON: I've treated a patient
with culture-proven Bacillus cereus keratitis following
flap lifting and irrigation for DLK. It returned aggressively
with an opaque flap and a melting, necrosing hinge.
I immediately lifted the flap, irrigated and applied
amikacin and vancomycin under it. The patient was admitted
to the hospital and eventually recovered 20/25 visual
acuity, and was happy enough to have the other eye
treated. If identified early and treated aggressively,
these patients can still have a good outcome.
RE-TREATMENTS
MS. SABBAGH: How do you manage
an undercorrection or an overcorrection?
DR. POP: I re-treat undercorrections
as soon as I diagnose them, but regression requires
a stable refraction before re-treatment, usually two
to three months. Overcorrected patients may also be
treated immediately postop.
DR. WILSON: I wait three months
to treat an undercorrection or regression. I have never
seen epithelial ingrowth beneath flaps I've lifted,
even on cases more than a year out. On the other hand,
I've consulted on patients who have had displaced slivers
of stroma that occurred during flap recutting for enhancement.
Where there's crossing of the initial interface with
the enhancement interface you risk some unusual tissue
displacement. If this happens, severe irregular astigmatism
can occur.
DR. KANELLOPOULOS: When recutting
a flap, it's very important to use the same microkeratome
to avoid transecting the original flap. With proper
technique, it is possible to lift the flap one-year
postop.
DR. POP: I lift the flap for all
re-treatments. I don't use a contact lens after the
initial surgery, but I always place a contact lens
after a re-treatment.
DR. CARLSON: I recut only if there
is a significant anomaly of the initial flap. Initially,
we were taught that lifting was best for re-treatments
in the first six months; recutting was suggested after
six months. The current thinking is that there is no
time limit for flap lifting in eyes with no neovascularization
or scarring at the flap edge.
Drs. Donnenfeld and Wilson consult
for Allergan; Drs. Carlson, Kanellopoulos and Pop
do not consult for any of the products or manufacturers
mentioned. REFERENCES
-
Corbett MC, O'Brart DP, Marshall
J. Do topical corticosteroids have a role following
excimer laser photorefractive keratectomy? J Refract
Surg 1995;11:380-7.
-
Wang Z, Cheng J, Yang B. Posterior
corneal surface topographic changes after laser
in situ keratomileusis are related to residual
corneal bed thickness. Ophthalmol 1999; 106:406-9;
discussion Robert Maloney, 409-10.
-
Reinstein DZ, Silverman RH, Raevsky
T, et al. Arc-scanning very high-frequency digital
ultrasound for 3D pachymetric mapping of the comeat
epithelium and stroma in laser in situ keratomileusis.
J Refract Surg 2000; 16:414-429.
-
Pop M. Relation between optical
zone, transition zone, limbus size and halos. Presentation:
Symposium on Cataract, IOL and Refractive Surgery;
American Society of Cataract and Refractive Surgery
annual meeting, April 2000; Boston, USA
-
Kapadia MS, Wilson SE. Transepithelial
photorefractive keratectomy for treatment of thin
flaps or caps after complicated laser in situ keratomileusis.
Am J Ophthalmol 1998; 126:827-9.
Source: Review of refractive
Surgery, September 2000 |